Clinical progress for the EGFR-TKI combined with radiotherapy in non-small cell lung cancer

VernacularTitle:EGFR-TKI联合放疗治疗非小细胞肺癌研究进展
Author: Juan LIN ; Shuiyun HAN ; Yaping XU
Publication Type:Journal Article
Keywords: Carcinoma,non-small-cell lung/TH; Receptor,epidermal growth factor/AI/TU; Protein-tyrosine kinases/AI/TU; Radiotherapy; Review
From: Journal of Chinese Physician 2016;18(6):813-817
CountryChina
Language:Chinese
Abstract: At present,the treatment for non-small cell lung cancer (NSCLC) consists of surgery,radiation,chemotherapy,targeted therapy,etc.The epidermal growth factor receptor (EGFR) gene mutation opened a new era of individualized treatment.Multidisciplinary treatment come next after the combination of different treatment approaches,and the modality of targeted therapy like epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in combination with radiation was included.The present work reviews clinical progress for the EGFR-TKI combined with radiotherapy in advanced NSCLC.